相关实验视频

Updated: Sep 9, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

对于固体瘤的CAR T细胞的基因工程:现状,障碍和未来发展

Rodrigo A Redondo-Frutos¹, Pedro Justicia-Lirio^1,2, Carmen Barbero-Jimenez¹

¹Hemato-Oncology Program, CIMA Universidad de Navarra, IdiSNA, Pamplona, Spain.

Human gene therapy

|August 29, 2025

概括

化学抗原受体 (CAR) T细胞疗法对固体瘤具有前景. 工程策略增强CAR T细胞的特异性,持久性和克服瘤微环境的能力,以改善癌症治疗.

科学领域:

免疫学
癌症学
生物技术

背景情况:

化学抗原受体 (CAR) T细胞疗法改变了血液癌症的治疗方法.
在固体瘤中阻碍CAR T细胞疗效的重大挑战包括抗原异质性,毒性,透性差,以及免疫抑制瘤微环境 (TME).

研究的目的:

审查旨在克服固体瘤中CAR T细胞治疗障碍的最新工程策略.
突出CAR T细胞设计的进步,以提高TME的安全性,特异性和持久性.

主要方法:

讨论关联调和逻辑关闭的CAR设计,以提高特异性和降低瘤外毒性.
探索多抗原向策略以对抗瘤异质性和抗原逃逸.
审查基因编辑技术以改善CAR T细胞适应性,记忆形成,代谢弹性和对TME介导抑制的抵抗力.

主要成果:

工程创新提高了CAR T细胞的定位精度和安全性.
多抗原向和基因编辑等策略可以改善CAR T细胞透,持续性和免疫抑制TME中的功能.
经过修改的CAR T细胞显示出降解细胞外基质的能力提高,并抵御瘤的恶劣条件.

结论:

合理的CAR设计和合成免疫学的进步为有效的固体瘤CART细胞疗法铺平了道路.
早期的临床试验显示出有希望的结果,表明可能会产生持久和安全的反应.
继续进行转化研究至关重要,以充分发挥CAR T细胞对固体瘤的治疗潜力.

关键词:

汽车T 美国基因工程固体瘤

更多相关视频

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...